Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Optaflu influenza vaccine (2007/2008 composition) in adult and elderly subjects
2007-001404-20Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of influenza vaccine in influenza, sponsored by Novartis. Primary endpoint: Measures of immunogenicity. Started Apr 2007; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-001404-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001404-20.